These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39039982)

  • 21. Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors.
    Yang C; Li C; Zhang P; Wu W; Jiang X
    Theranostics; 2017; 7(6):1719-1734. PubMed ID: 28529647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone.
    Sargazi A; Kamali N; Shiri F; Heidari Majd M
    Artif Cells Nanomed Biotechnol; 2018 May; 46(3):500-509. PubMed ID: 28503952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theranostic Hyaluronic Acid-Iron Micellar Nanoparticles for Magnetic-Field-Enhanced in vivo Cancer Chemotherapy.
    Wang G; Gao S; Tian R; Miller-Kleinhenz J; Qin Z; Liu T; Li L; Zhang F; Ma Q; Zhu L
    ChemMedChem; 2018 Jan; 13(1):78-86. PubMed ID: 29086481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
    Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
    Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the applications of hyaluronic acid-based nanoparticles for diagnosis and treatment of bacterial infections.
    Mohammed M; Devnarain N; Elhassan E; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1799. PubMed ID: 35485247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD44-Targeted Hyaluronic Acid-Coated Redox-Responsive Hyperbranched Poly(amido amine)/Plasmid DNA Ternary Nanoassemblies for Efficient Gene Delivery.
    Gu J; Chen X; Ren X; Zhang X; Fang X; Sha X
    Bioconjug Chem; 2016 Jul; 27(7):1723-36. PubMed ID: 27311558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
    Sargazi A; Shiri F; Keikha S; Majd MH
    Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy.
    Wang J; Muhammad N; Li T; Wang H; Liu Y; Liu B; Zhan H
    Mol Pharm; 2020 Jul; 17(7):2411-2425. PubMed ID: 32437163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Arch Pharm Res; 2017 Dec; 40(12):1420-1432. PubMed ID: 29027133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in hyaluronic acid-based nanomedicines: Preparation and application in cancer therapy.
    Hou X; Zhong D; Chen H; Gu Z; Gong Q; Ma X; Zhang H; Zhu H; Luo K
    Carbohydr Polym; 2022 Sep; 292():119662. PubMed ID: 35725165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid Nanoparticles Modified by Hyaluronic Acid Loading an HSP90 Inhibitor as a Novel Delivery System for Subcutaneous and Orthotopic Colon Cancer Therapy.
    Pan C; Zhang T; Li S; Xu Z; Pan B; Xu S; Jin S; Lu G; Yang S; Xue Z; Chen P; Shen X; Wang F; Xu C
    Int J Nanomedicine; 2021; 16():1743-1755. PubMed ID: 33688189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation.
    Seok HY; Sanoj Rejinold N; Lekshmi KM; Cherukula K; Park IK; Kim YC
    J Control Release; 2018 Jun; 280():20-30. PubMed ID: 29723613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaluronic Acid: A Key Ingredient in the Therapy of Inflammation.
    Marinho A; Nunes C; Reis S
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
    Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
    Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy.
    Edelman R; Assaraf YG; Levitzky I; Shahar T; Livney YD
    Oncotarget; 2017 Apr; 8(15):24337-24353. PubMed ID: 28212584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines.
    Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Biomed Pharmacother; 2020 May; 125():109988. PubMed ID: 32059173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyaluronic acid-based carriers for tumor targeted delivery system].
    Qiu LP; Long MM; Chen DW
    Yao Xue Xue Bao; 2013 Sep; 48(9):1376-82. PubMed ID: 24358769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells.
    Mansoori B; Mohammadi A; Abedi-Gaballu F; Abbaspour S; Ghasabi M; Yekta R; Shirjang S; Dehghan G; Hamblin MR; Baradaran B
    J Cell Physiol; 2020 Oct; 235(10):6817-6830. PubMed ID: 31989649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyaluronic acid conjugates as vectors for the active targeting of drugs, genes and nanocomposites in cancer treatment.
    Arpicco S; Milla P; Stella B; Dosio F
    Molecules; 2014 Mar; 19(3):3193-230. PubMed ID: 24642908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.